Paperpal Prime Logo

Cancer Science : Impact Factor & More

eISSN: 1349-7006pISSN: 1347-9032
JournalOpen Access

Aims and Scope of Cancer Science

Cancer Science is a monthly peer-reviewed medical journal covering research in oncology, which is published by Wiley-Blackwell on behalf of the Japanese Cancer Association. Established in 1907, the journal publishes original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational, and clinical cancer research. The editor-in-chief is Kohei Miyazono (University of Tokyo). According to the Journal Citation Reports, the journal has a 2020 impact factor of 6.71, ranking it 50 out of 242 journals in the category "Oncology". Less

Key Metrics

CiteScore
10
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
SJR
Q1Oncology
SNIP
1.44
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Science

Cancer Science Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
Article Processing ChargesUSD 2250
Publication Time17
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorJapanese Cancer Association
FrequencyMonthly
Publication Start Year2003
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 17
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Cancer Science ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Science

Five\u2010Year Trends in Biomarker Testing and Targeted Therapy for NSCLC: A Patient\u2010Initiated Nationwide Survey in Japan
  • 7 Aug 2026
  • Cancer Science
CircHECTD1 Promotes Cholangiocarcinoma Progression Through Interaction With SFPQ to Induce Autophagy.
  • 7 Aug 2026
  • Cancer science
Daraxonrasib and Beyond: Pan\u2010RAS Inhibition, Resistance, and Next\u2010Generation Strategies
  • 6 Aug 2026
  • Cancer Science
LAMC2+ Epithelial Cells Drive Bladder Cancer Progression and Predict Immunotherapy Response via SERPINB3/STAT3/CD44 Axis
  • 5 Aug 2026
  • Cancer Science
Targeted Photo\u2010Induced Elimination of Tumor\u2010Associated Macrophages Suppresses Cancer Progression in a Murine Model
  • 4 Aug 2026
  • Cancer Science
TRNA\u2010Derived Small RNAs in Digestive Cancers: From Translational Regulation to Immune and Extracellular Communication
  • 4 Aug 2026
  • Cancer Science
Five\u2010Year Trends in Biomarker Testing and Targeted Therapy for NSCLC: A Patient\u2010Initiated Nationwide Survey in Japan
  • 7 Aug 2026
  • Cancer Science
CircHECTD1 Promotes Cholangiocarcinoma Progression Through Interaction With SFPQ to Induce Autophagy.
  • 7 Aug 2026
  • Cancer science
Daraxonrasib and Beyond: Pan\u2010RAS Inhibition, Resistance, and Next\u2010Generation Strategies
  • 6 Aug 2026
  • Cancer Science
LAMC2+ Epithelial Cells Drive Bladder Cancer Progression and Predict Immunotherapy Response via SERPINB3/STAT3/CD44 Axis
  • 5 Aug 2026
  • Cancer Science
Targeted Photo\u2010Induced Elimination of Tumor\u2010Associated Macrophages Suppresses Cancer Progression in a Murine Model
  • 4 Aug 2026
  • Cancer Science
TRNA\u2010Derived Small RNAs in Digestive Cancers: From Translational Regulation to Immune and Extracellular Communication
  • 4 Aug 2026
  • Cancer Science

FAQs on Cancer Science